NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations:: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

被引:203
作者
Nguyen, S
Dhedin, N
Vernant, JP
Kuentz, M
Al Jijakli, A
Rouas-Freiss, N
Carosella, ED
Boudifa, A
Debré, P
Vieillard, V
机构
[1] Hop La Pitie Salpetriere, INSERM, U543, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France
[2] Hop La Pitie Salpetriere, Serv Hematol Clin, F-75013 Paris, France
[3] Hop Henri Mondor, Serv Hematol Clin, F-94010 Creteil, France
[4] Hop St Louis, CEA, Paris, France
关键词
D O I
10.1182/blood-2004-10-4113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural killer (NK) cell alloreactivity is reported to mediate strong GvL (graft versus leukemia) effect in patients after haploidentical stem-cell transplantation (SCT) for acute myeloid leukemia (AML). Because subsequent immune reconstitution remains a major concern, we studied NK-cell recovery in 10 patients with AML who received haplomismatched SC transplants, among whom no GvL effect was observed, despite the mismatched immunoglobulln-like receptor (KIR) ligand in the GvH direction for 8 of 10 patients. NK cells generated after SCT exhibited an immature phenotype: the cytotoxic CD3-CD56(dim) subset was small, expression of KIRs and NKp30 was reduced, while CD94/NKG2A expression was increased. This phenotype was associated to in vitro lower levels of cytotoxicity against a K562 cell line and against primary mismatched AML blasts than donor samples. This impaired lysis was correlated with CD94/NKG2A expression in NK cells. Blockading CD94/NKG2A restored lysis against the AML blasts, which all expressed HILA-E, the ligand for CD94/ NKG2A. Our present study allows a better understanding of the NK-cell differentiation after SCT. These results revealed that the NK cells generated after haplomismatched SCT are blocked at an immature state characterized by specific phenotypic features and impaired functioning, having potential impact for immune responsiveness and transplantation outcome. (c) 2005 by The American Society of Hematology.
引用
收藏
页码:4135 / 4142
页数:8
相关论文
共 45 条
[1]   EFFECT OF HLA COMPATIBILITY ON ENGRAFTMENT OF BONE-MARROW TRANSPLANTS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA [J].
ANASETTI, C ;
AMOS, D ;
BEATTY, PG ;
APPELBAUM, FR ;
BENSINGER, W ;
BUCKNER, CD ;
CLIFT, R ;
DONEY, K ;
MARTIN, PJ ;
MICKELSON, E ;
NISPEROS, B ;
OQUIGLEY, J ;
RAMBERG, R ;
SANDERS, JE ;
STEWART, P ;
STORB, R ;
SULLIVAN, KM ;
WITHERSPOON, RP ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :197-204
[2]   SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM [J].
AVERSA, F ;
TABILIO, A ;
TERENZI, A ;
VELARDI, A ;
FALZETTI, F ;
GIANNONI, C ;
IACUCCI, R ;
ZEI, T ;
MARTELLI, MP ;
GAMBELUNGHE, C ;
ROSSETTI, M ;
CAPUTO, P ;
LATINI, P ;
ARISTEI, C ;
RAYMONDI, C ;
REISNER, Y ;
MARTELLI, MF .
BLOOD, 1994, 84 (11) :3948-3955
[3]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[4]   The beneficial role of inhibitory KIR genes of HLA class INK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD [J].
Bishara, A ;
De Santis, D ;
Witt, CC ;
Brautbar, C ;
Christiansen, FT ;
Or, R ;
Nagler, A ;
Slavin, S .
TISSUE ANTIGENS, 2004, 63 (03) :204-211
[5]   Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors [J].
Bornhäuser, M ;
Schwerdtfeger, R ;
Martin, H ;
Frank, KH ;
Theuser, C ;
Ehninger, G .
BLOOD, 2004, 103 (07) :2860-2861
[6]  
Campbell K S, 2001, Int Rev Immunol, V20, P333, DOI 10.3109/08830180109054413
[7]   Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand [J].
Chklovskaia, E ;
Nowbakht, P ;
Nissen, C ;
Gratwohl, A ;
Bargetzi, M ;
Wodnar-Filipowicz, A .
BLOOD, 2004, 103 (10) :3860-3868
[8]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[9]   Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset [J].
Cooper, MA ;
Fehniger, TA ;
Turner, SC ;
Chen, KS ;
Ghaheri, BA ;
Ghayur, T ;
Carson, WE ;
Caligiuri, MA .
BLOOD, 2001, 97 (10) :3146-3151
[10]   Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants [J].
Davies, SM ;
Ruggieri, L ;
DeFor, T ;
Wagner, JE ;
Weisdorf, DJ ;
Miller, JS ;
Velardi, A ;
Blazar, BR .
BLOOD, 2002, 100 (10) :3825-3827